Menu

Chimeric Pancreas Treats Diabetes in Mice

Researchers produce functional organs composed of both mouse and rat cells.

Jan 26, 2017
Tracy Vence

WIKIMEDIA, JAKOB SUCKALEBy injecting murine pluripotent stem cells into specialized rat blastocysts, scientists at the University of Toyko generated a functional mouse-rat chimeric pancreas, according to a study published this week (January 25) in Nature. Transplanted into a mouse that had been engineered to model diabetes, the chimeric pancreas maintained the rodent’s blood-glucose levels for more than a year.  “This is the first time this kind of inter-species organ generation has successfully treated a medical condition,” New Scientist reported.

“There are not that many ways to generate a functional adult human organ for transplantation that can save many people’s lives,” Qiao Zhou of the Harvard Stem Cell Institute who was not involved in the study told The Verge. “This is one I think actually I can see work in the future.”

While researchers have their sights set on generating other chimeric organs, ethical challenges remain. “The biological issues and the ethical issues are still in very preliminary phase,” Timo Otonkoski of the University of Helsinki in Finland told The Verge. “It’s still very hard to know if this has any real potential for human medicine. But it’s interesting biology and it’s interesting to explore whether these possibilities are real or not.”

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
NRGene has launched a new product that aims to empower breeding and maximize agricultural yield as part of the Denovo assembly product suite offered by the company.
Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.